"NYC Health + Hospitals/Elmhurst’s long-standing mission has been to deliver affordable, high-quality healthcare to the people of Queens. In addition to providing outstanding pediatric and adult primary care, we offer a broad range of healthcare services for women of all ages."

During the past decade, Elmhurst Hospital Center conducted 11 clinical trials. In the 10-year time frame, 11 clinical trials started and 16 clinical trials were completed, i.e. on average, 145.5% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 8 clinical trials were completed. i.e. 114.3% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Elmhurst Hospital Center" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 29 trials, followed by "National Institute of Allergy and Infectious Diseases (NIAID)" with 17 trials sponsored, "National Cancer Institute (NCI)" with 8 trials sponsored, "Icahn School of Medicine at Mount Sinai" with 6 trials sponsored and "SWOG Cancer Research Network" with 6 trials sponsored. Other sponsors include 12 different institutions and companies that sponsored additional 20 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Elmhurst Hospital Center" #1 collaborator was "National Cancer Institute (NCI)" with 39 trials as a collaborator, "Bristol-Myers Squibb" with 6 trials as a collaborator, "Cancer and Leukemia Group B" with 4 trials as a collaborator, "Eastern Cooperative Oncology Group" with 3 trials as a collaborator and "Canadian Cancer Trials Group" with 2 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 25 trials.

According to Clinical.Site data, the most researched conditions in "Elmhurst Hospital Center" are "HIV Infections" (21 trials), "Breast Cancer" (9 trials), "Lung Cancer" (9 trials), "Colorectal Cancer" (6 trials) and "Lymphoma" (6 trials). Many other conditions were trialed in "Elmhurst Hospital Center" in a lesser frequency.

Most popular intervention types in "Elmhurst Hospital Center" are "Drug" (59 trials), "Other" (21 trials), "Biological" (12 trials), "Procedure" (7 trials) and "Radiation" (6 trials). Other intervention types were less common.

The name of intervention was led by "Zidovudine" (12 trials), "Laboratory Biomarker Analysis" (7 trials), "placebo" (6 trials), "Didanosine" (5 trials) and "Quality-of-Life Assessment" (5 trials). Other intervention names were less common.

The vast majority of trials in "Elmhurst Hospital Center" are 62 trials for "All" genders, 14 trials for "Female" genders and 4 trials for "Male" genders.

Currently, there are NaN active trials in "Elmhurst Hospital Center". undefined are not yet recruiting, 1 are recruiting, 14 are Active, not recruiting, and 1 are Enrolling by invitation. In total, there were 59 completed trials in Elmhurst Hospital Center, undefined suspended trials, and 5 terminated clinical trials to date.

Out of the total trials that were conducted in Elmhurst Hospital Center, 3 "Phase 1" clinical trials were conducted, 29 "Phase 2" clinical trials and 31 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 11 trials that are defined as “Not Applicable".